Scientia Advisors in the News

---

Publications

---

Press Releases

---

Events

---

Luminary Insights

---

Media Contact

---

Scientia Advisors in the News

Boston Globe quotes Harry Glorikian in article on "Genzyme to slash 1,000 positions - Worldwide cuts as firm fends off buyer"

Robert Weisman and Steven Syre
September 11, 2010

In this article, Robert Weisman and Steven Syre of The Boston Globe quote Harry Glorikian, Scientia Advisors' Managing Partner, who believes Genzyme could benefit from an internal review of operations: "I wouldn't call it fat, but you're so busy running forward, sometimes you don't look back as often as you should."

Read the full article at: The Boston Globe